Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Name: Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology
SKU: 3245
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 1 Articles Tags: aliou-d-ousmanou, drug-interactions, drug-transport-protein, inducer, inhibitor, multidrug-resistance, p-glycoprotein, sheri-l-hoyler, stanley-w-carson, substrate

Description

Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Description

Stanley W. Carson

DRUG INTERACTIONS

Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Stanley W. Carson, PharmD, FCCP, BCPP, Aliou D. Ousmanou, PharmD, and Sheri L. Hoyler, PharmD

Po W. Wang, MD: Pharmacokinetics of Mood Stabilizers and New Anticonvulsants

The 2018 Handbook of Psychotropic Drug Interactions

Psychotropic Drug Interactions: A Doctor’s Guide

Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients

Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Description

Stanley W. Carson

DRUG INTERACTIONS

Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Stanley W. Carson, PharmD, FCCP, BCPP, Aliou D. Ousmanou, PharmD, and Sheri L. Hoyler, PharmD

Related products

Po W. Wang, MD: Pharmacokinetics of Mood Stabilizers and New Anticonvulsants

The 2018 Handbook of Psychotropic Drug Interactions

Psychotropic Drug Interactions: A Doctor’s Guide

Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients